EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 14

Ensembl ID : ENSLCRG00005011795
Gene Symbol: PSMD14
3 Cross references
214 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 6

Ensembl ID : ENSLCRG00005002914
Gene Symbol: PSMD6
3 Cross references
212 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 7

Ensembl ID : ENSLCRG00005014162
Gene Symbol: PSMD7
3 Cross references
235 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSLCRG00005015390
Gene Symbol: PSMD8
3 Cross references
211 Possible Orthologues:

Proteasome Subunit Alpha Type-6

Ensembl ID : ENSLCRG00005015849
Gene Symbol: LOC104931205
3 Cross references
278 Possible Orthologues:

Proteasome Subunit Beta 11

Ensembl ID : ENSLCRG00005011085
Gene Symbol: PSMB11
1 Cross references
169 Possible Orthologues:

Proteasome Subunit Beta Type-11

Ensembl ID : ENSLCRG00005001021
Gene Symbol: LOC104919141
3 Cross references
159 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSLCRG00005011045
Gene Symbol: PRMT5
3 Cross references
198 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSLCRG00005011439
Gene Symbol: PRKCB
3 Cross references
207 Possible Orthologues:

Protein Kinase C Beta Type

Ensembl ID : ENSLCRG00005012152
Gene Symbol: LOC104929965
3 Cross references
223 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSLCRG00005009015
Gene Symbol: PRKCD
3 Cross references
203 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSLCRG00005015959
Gene Symbol: PRKCE
3 Cross references
249 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).